Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens.
A therapeutic dendritic cell-based vaccine for HIV-1 infection.
Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1.
Drug uptake transporters in antiretroviral therapy.
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
β5 integrin is the major contributor to the αVintegrin-mediated blockade of HIV-1 replication.
RNA interference as a tool for exploring HIV-1 robustness.
Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients.
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.